Does GILTERITINIB Cause Product use issue? 189 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 189 reports of Product use issue have been filed in association with GILTERITINIB (Xospata). This represents 5.2% of all adverse event reports for GILTERITINIB.
189
Reports of Product use issue with GILTERITINIB
5.2%
of all GILTERITINIB reports
55
Deaths
50
Hospitalizations
How Dangerous Is Product use issue From GILTERITINIB?
Of the 189 reports, 55 (29.1%) resulted in death, 50 (26.5%) required hospitalization, and 9 (4.8%) were considered life-threatening.
Is Product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GILTERITINIB. However, 189 reports have been filed with the FAERS database.
What Other Side Effects Does GILTERITINIB Cause?
Acute myeloid leukaemia (366)
Febrile neutropenia (346)
Off label use (334)
Platelet count decreased (327)
Pneumonia (302)
Myelosuppression (300)
Pyrexia (281)
Death (206)
Hepatic function abnormal (181)
Neutrophil count decreased (162)
What Other Drugs Cause Product use issue?
INFLIXIMAB (12,752)
DUPILUMAB (10,575)
POLYETHYLENE GLYCOL 3350 (9,432)
METHOTREXATE (8,185)
DICLOFENAC (8,009)
RITUXIMAB (6,948)
ADALIMUMAB (6,379)
ETANERCEPT (6,062)
TOCILIZUMAB (5,944)
ABATACEPT (5,915)
Which GILTERITINIB Alternatives Have Lower Product use issue Risk?
GILTERITINIB vs GIMERACIL\OTERACIL\TEGAFUR
GILTERITINIB vs GINKGO
GILTERITINIB vs GIVINOSTAT
GILTERITINIB vs GIVOSIRAN
GILTERITINIB vs GLASDEGIB